Log In

EDRN Catalog and Archive Service


FHCRC Tewari Raw Cp below No Enz RT

Dataset Abstract:

Exiqon microRNA PCR Human Panel I+II, V1 April-May 2010


The following additional information has been defined for this dataset. The information has been provided by the Principal Investigator or staff from his or her laboratory.

Additional information may exist that is not visible due to your current access permissions.
ProtocolID
282
ProtocolName
Identification of biomarkers for lung cancer in never smokers
DataSetName
FHCRC Tewari Raw Cp below No Enz RT
LeadPI
Canary
SiteName
Canary Foundation
DataCustodian
DataCustodianEmail
TBD
OrganSite
Lung
CollaborativeGroup
Lung and Upper Aerodigestive
Date
2010-12-15T15:59:00.000Z
QAState
Under Review
InstrumentDetails
Roche Light Cycler 480
Technology
Roche Light Cycler 480
StudyName
Canary Never Smokers
StudyId
282
InvestigatorName
Muneesh Tewari
SpecimenType
microRNA PCR
Description
Exiqon microRNA PCR Human Panel I II, V1 April-May 2010
DataDisclaimer
Data and information released from the National Cancer Institute (NCI) are provided on an "AS IS" basis, without warranty of any kind, including without limitation the warranties of merchantability, fitness for a particular purpose and non-infringement. Availability of this data and information does not constitute scientific publication. Data and/or information may contain errors or be incomplete. NCI and its employees make no representation or warranty, express or implied, including without limitation any warranties of merchantability or fitness for a particular purpose or warranties as to the identity or ownership of data or information, the quality, accuracy or completeness of data or information, or that the use of such data or information will not infringe any patent, intellectual property or proprietary rights of any party. NCI shall not be liable for any claim for any loss, harm, illness or other damage or injury arising from access to or use of data or information, including without limitation any direct, indirect, incidental, exemplary, special or consequential damages, even if advised of the possibility of such damages. In accordance with scientific standards, appropriate acknowledgment of NCI should be made in any publications or other disclosures concerning data or information made available by NCI.